Literature DB >> 6818155

Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

I Haller.   

Abstract

The effect of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa was examined. Logarithmically growing bacterial cultures were incubated in an ultrafiltration cell, and after adding the antibiotics, the culture medium was diluted every 20 min without any decrease in cell density. The turn-over of medium resulted in the elimination of azlocillin with a half-life of 75 min. This simulated serum kinetics in vivo. When testing sisomicin, small amounts of this agent were added during every dilution step to achieve a half-life of 120 min. Growth conditions were comparable in all experiments. The simultaneous combination of azlocillin and sisomicin resulted in strong synergism as assessed by higher killing rates and more prolonged growth inhibition of surviving bacteria. Comparable results were observed when both drugs were added at intervals of 40 min. When applied at intervals of 120 min, the combined effect of azlocillin and sisomicin was reduced, but still superior to the effect of double the concentration of each compound alone. Thus, neither pre-treatment with azlocillin nor with sisomicin impaired the antibacterial activity of the combination partner. This seems to be of clinical importance since the agents may be administered at different times during combined therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818155     DOI: 10.1007/bf01640679

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  18 in total

1.  Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1975-04

2.  THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN.

Authors:  H Eagle; A D Musselman
Journal:  J Bacteriol       Date:  1949-10       Impact factor: 3.490

3.  In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection.

Authors:  M J Al-Asadi; D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

4.  An experimental model for the study of the antibacterial activity of the sulfonamides.

Authors:  A Sanfilippo; E Morvillo
Journal:  Chemotherapia (Basel)       Date:  1968

5.  Laboratory evaluation of FR10612, a new oral cephalosporin derivative.

Authors:  M Nishida; T Murakawa; T Kamimura; N Okada; H Sakamoto
Journal:  J Antibiot (Tokyo)       Date:  1976-04       Impact factor: 2.649

6.  An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions.

Authors:  T Bergan; I B Carlsen; J E Fuglesang
Journal:  Infection       Date:  1980       Impact factor: 3.553

7.  Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration.

Authors:  U Klaus; W Henninger; P Jacobi; B Wiedemann
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

8.  New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Authors:  T Murakawa; H Sakamoto; T Hirose; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

9.  Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.

Authors:  M Nishida; T Murakawa; T Kamimura; N Okada
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

10.  Bacterial kill rates of amoxycillin and ampicillin at exponentially diminishing concentrations simulating in vivo conditions.

Authors:  T Bergan; I B Carlsen
Journal:  Infection       Date:  1980       Impact factor: 3.553

View more
  1 in total

1.  A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of Molecules.

Authors:  Sarah Y Lockwood; Jayda E Meisel; Frederick J Monsma; Dana M Spence
Journal:  Anal Chem       Date:  2016-01-15       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.